Skip to main content
Borosil Scientific Limited logo

Borosil Scientific Limited — Investor Relations & Filings

Ticker · BOROSCI ISIN · INE02L001032 LEI · 9845000KHFF9A4F3BF28 BSE.NS Manufacturing
Open in API
Filings indexed 122 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS BOROSCI

About Borosil Scientific Limited

https://www.borosilscientific.com

Borosil Scientific Limited specializes in the manufacture and distribution of high-quality laboratory glassware and scientific instruments. The company provides a comprehensive range of products, including beakers, flasks, cylinders, pipettes, and specialized laboratory apparatus designed for precision and durability. Its offerings cater to diverse sectors such as pharmaceuticals, biotechnology, research and development, and educational institutions. Utilizing advanced borosilicate glass technology, the company ensures its products exhibit superior thermal shock resistance and chemical durability. In addition to glassware, the portfolio includes laboratory equipment and primary packaging solutions for the healthcare industry. Borosil Scientific Limited is recognized for its commitment to accuracy and international quality standards, supporting critical scientific processes and industrial applications.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the Financial Year 2025-26
Regulatory Filings Classification · 85% confidence The document is titled “Annual Secretarial Compliance Report” filed under Regulation 24A of SEBI LODR Regulations. It is a compliance certificate/attestation by the Company Secretary and does not constitute a financial report (e.g., Annual Report, Interim Report) nor a corporate governance charter, but rather a regulatory compliance filing. Per the CERTIFICATION RULE, officer certifications and compliance attestations are classified as Regulatory Filings (RNS).
2026-05-22 English
Options to purchase securities
Share Issue/Capital Change Classification · 90% confidence The document is a formal intimation to stock exchanges under SEBI LODR regulations announcing the grant of 18,700 employee stock options under the company’s ESOP scheme. It is not a management discussion, earnings release, or AGM material, nor is it a director’s personal trade. It deals with the allotment/issuance of equity-linked instruments (options) that will eventually change the company’s capital base upon exercise. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-20 English
Grant of Stock Options under Borosil Scientific Limited- Employee Stock Option Scheme
Share Issue/Capital Change Classification · 82% confidence The document is an official stock exchange filing under SEBI LODR Regulations notifying the grant of 18,700 employee stock options under the company’s ESOP scheme. It details grant terms, vesting schedule, pricing and share impact. This is a corporate action announcing a future share issuance under an employee option plan, which constitutes a change in share capital. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2026-05-20 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-20 English
Re-appointment of Mr. Vinayak Madhukar Patankar as Whole-Time Director.
Earnings Release Classification · 78% confidence The document is a formal intimation to stock exchanges under SEBI Listing Regulation 30 announcing the outcomes of a board meeting held May 20, 2026. The key items include the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, issuance of the auditor’s report with unmodified opinion, and details of management (KMP) changes. This is not the full annual report (10-K) nor a proxy or dividend notice; it is the company’s official earnings announcement of quarterly/annual financial results filed with exchanges. Accordingly, it falls under “Earnings Release” (ER). FY 2026
2026-05-20 English
Appointment of Company Secretary & Compliance Officer
Regulatory Filings Classification · 82% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the stock exchanges of the outcomes of a Board Meeting – including approval of audited financial results, auditor’s report, re-appointment and resignation of key managerial personnel, and authorization of KMPs. It is not the full Annual Report, a detailed interim report, nor merely a management presentation, but rather a regulatory announcement of material events. Hence it falls under General Regulatory Filings (RNS).
2026-05-20 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.